IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
87.36
-1.14 (-1.29%)
May 19, 2026, 4:00 PM EDT - Market closed

IRADIMED CORPORATION Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
23.6122.4819.2317.1912.839.33
Depreciation & Amortization
1.431.170.820.770.671.41
Stock-Based Compensation
2.782.922.522.191.391.46
Other Adjustments
2.572.73-0.7-0.770.210.64
Change in Receivables
-0.68-3.031.760.84-8.24-0.58
Changes in Inventories
-1.79-1.383.13-7.47-1.31-0.39
Changes in Accounts Payable
-0.41-0.08-0.86-0.221.120.03
Changes in Accrued Expenses
-0.2-0.551-0.10.061.1
Changes in Income Taxes Payable
-1.49-0.76-0.790.253.05-0.83
Changes in Unearned Revenue
1.351.6-0.110.620.530.05
Changes in Other Operating Activities
-0.44-0.15-0.380.16-0.27-0.96
Operating Cash Flow
28.9524.9525.6213.4710.0411.26
Operating Cash Flow Growth
11.19%-2.64%90.30%34.08%-10.80%93.52%
Capital Expenditures
-4.47-7.77-8.01-7.44-0.82-0.48
Purchases of Intangible Assets
-0.5-0.66-0.81-0.57-1.05-0.26
Proceeds from Sale of Investments
----0.51.39
Investing Cash Flow
-4.97-8.42-8.82-8.01-1.380.65
Issuance of Common Stock
--0.030.180.150.62
Repurchase of Common Stock
-2.5-2.56-0.69-0.61-0.29-0.6
Net Common Stock Issued (Repurchased)
-2.5-2.56-0.66-0.43-0.150.02
Common Dividends Paid
-15.43-15.04-13.68-13.22-12.56-
Financing Cash Flow
-17.93-17.6-14.34-13.66-12.710.02
Net Cash Flow
6.04-1.082.47-8.2-4.0411.93
Free Cash Flow
24.4717.1817.626.029.2210.78
Free Cash Flow Growth
42.44%-2.48%192.46%-34.66%-14.44%100.50%
FCF Margin
28.37%20.50%24.06%9.19%17.30%25.77%
Free Cash Flow Per Share
1.901.341.380.470.730.86
Levered Free Cash Flow
17.5914.5614.043.7715.869.25
Unlevered Free Cash Flow
15.8412.8112.22.4215.429.23
Updated May 1, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q